These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8537721)

  • 1. [Countermeasure for patients with anemia due to hemodialysis].
    Suzuki M
    Nihon Naika Gakkai Zasshi; 1995 Oct; 84(10):1663-7. PubMed ID: 8537721
    [No Abstract]   [Full Text] [Related]  

  • 2. [Utility of recombinant human erythropoietin on the anemia of elderly hemodialysis patients].
    Ueyama H; Nakahashi H; Sawanishi K; Kuze M; Ono T
    Hinyokika Kiyo; 1992 Dec; 38(12):1429-35. PubMed ID: 1288237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The importance of erythropoietin in the therapy of anemia in patients on chronic hemodialysis].
    von Appen K; Klinkmann H
    Urol Nefrol (Mosk); 1990; (6):69-70. PubMed ID: 2089771
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of the chronic renal failure patient receiving epoetin alfa for the treatment of anemia.
    Binkley LS
    Transplant Proc; 1991 Apr; 23(2):1831-2. PubMed ID: 2053169
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythropoietin for anemia of renal failure in sickle cell disease.
    Steinberg MH
    N Engl J Med; 1991 May; 324(19):1369-70. PubMed ID: 1759999
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant erythropoietin for the anemia of chronic renal failure.
    Ahmad R; Hand M
    N Engl J Med; 1987 Jul; 317(3):169-70. PubMed ID: 3600706
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diagnosis and therapy of renal anemia].
    Hara S
    Nihon Naika Gakkai Zasshi; 1999 Jun; 88(6):1029-34. PubMed ID: 10465946
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in quality of life and functional capacity in hemodialysis patients treated with recombinant human erythropoietin. The Canadian Erythropoietin Study Group.
    Laupacis A
    Semin Nephrol; 1990 Mar; 10(2 Suppl 1):11-9. PubMed ID: 2192412
    [No Abstract]   [Full Text] [Related]  

  • 9. The anemia of chronic renal failure: pathophysiology and effects of recombinant erythropoietin.
    Eschbach JW; Haley NR; Adamson JW
    Contrib Nephrol; 1990; 78():24-36; discussion 37. PubMed ID: 2225841
    [No Abstract]   [Full Text] [Related]  

  • 10. Quality of life: subjective and objective improvements with recombinant human erythropoietin therapy.
    Lundin AP
    Semin Nephrol; 1989 Mar; 9(1 Suppl 1):22-9. PubMed ID: 2648517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.
    Korbet SM
    Kidney Int Suppl; 1993 Feb; 40():S111-9. PubMed ID: 8445832
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of anemia in chronically dialyzed patients].
    Moynot A
    Nephrologie; 1998; 19(3):125-7. PubMed ID: 9633055
    [No Abstract]   [Full Text] [Related]  

  • 13. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].
    Jalil R; Vaccarezza A; Jara A; Lira P; Vial S; Serrano V
    Rev Med Chil; 1990 Jun; 118(6):629-34. PubMed ID: 1775783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of human recombinant erythropoietin (rHuEPO) for treatment of anemia in patients with chronic kidney failure who don't require additional dialysis therapy].
    Wiecek A
    Przegl Lek; 1995; 52(3):93-4. PubMed ID: 7644683
    [No Abstract]   [Full Text] [Related]  

  • 15. [The abnormalities of blood cells in chronic kidney failure with long-term dialysis].
    Narita M; Shibata A
    Nihon Rinsho; 1992 Jan; 50 Suppl():763-70. PubMed ID: 1578764
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of recombinant human erythropoietin on hemodynamics in chronic hemodialysis patients].
    Tomura S
    Nihon Rinsho; 1991 Dec; 49 Suppl():695-701. PubMed ID: 1808338
    [No Abstract]   [Full Text] [Related]  

  • 17. [Complications of long-term hemodialysis patients and the countermeasures].
    Asano Y
    Nihon Naika Gakkai Zasshi; 1992 Aug; 81(8):1273-8. PubMed ID: 1431471
    [No Abstract]   [Full Text] [Related]  

  • 18. [Erythropoietin: the significance in therapeutic system of renal failure; clinical efficacy of erythropoietin].
    Nihon Jinzo Gakkai Shi; 1989 May; 31(5):435-9. PubMed ID: 2622074
    [No Abstract]   [Full Text] [Related]  

  • 19. Erythropoietin use in peritoneal dialysis patients.
    Zimmerman SW; Johnson CA
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):38-41. PubMed ID: 1928078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin treatment improves quality of life in hemodialysis patients.
    Bárány P; Pettersson E; Bergström J
    Scand J Urol Nephrol Suppl; 1990; 131():55-60. PubMed ID: 2075471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.